Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
4.070
+0.100 (2.52%)
Nov 21, 2024, 11:25 AM EST - Market open
Cibus Employees
Cibus had 183 employees as of December 31, 2023. The number of employees increased by 135 or 281.25% compared to the previous year.
Employees
183
Change (1Y)
135
Growth (1Y)
281.25%
Revenue / Employee
$22,694
Profits / Employee
-$2,433,880
Market Cap
120.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Adverum Biotechnologies | 121 |
TriSalus Life Sciences | 112 |
Compugen | 68 |
Candel Therapeutics | 42 |
Zentek | 24 |
Avalo Therapeutics | 19 |
Cardiol Therapeutics | 6 |
CBUS News
- 2 days ago - Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape - GlobeNewsWire
- 3 days ago - Cibus to Participate in the 13th Annual Roth Technology Conference - GlobeNewsWire
- 11 days ago - Cibus, Inc. (CBUS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024 - GlobeNewsWire
- 16 days ago - Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola - GlobeNewsWire
- 4 weeks ago - Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call - GlobeNewsWire
- 4 weeks ago - Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities - GlobeNewsWire
- 5 weeks ago - Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress - GlobeNewsWire